Navigation Links
eResearchTechnology Reports Third Quarter 2008 Results
Date:10/30/2008

(62,190) (62,190)

Total stockholders' equity 113,512 135,952

Total liabilities and

stockholders' equity $147,696 $166,325

eResearchTechnology, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

Nine Months Ended September 30,

2007 2008

Operating activities:

Net income $10,093 $19,336

Adjustments to reconcile net

income to net cash provided

by operating activities:

Depreciation and amortization 11,066 12,519

Cost of sales of equipment 1,004 717

Provision for

uncollectible accounts - 60

Share-based compensation 1,576 1,966

Deferred income taxes 482 (1,151)

Changes in operating assets

and liabilities excluding CCSS

acquisition:

Accounts receivable (3,777) (6,601)

Prepaid expenses and other (595) (1,560)

Accounts payable (1,888) 357

Accrued expenses 1,500 (540)

Income taxes 2,267 931

Deferred revenues 995 747

Net cash provided by

operating activities 22,723 26,781 '/>"/>

SOURCE eResearchTechnology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
2. eResearchTechnology to Present at the UBS Global Healthcare Services Conference 2008 on February 11th
3. eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 2008
4. eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
5. eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
6. eResearchTechnology, Inc. to Announce 2008 First Quarter Results on May 5, 2008
7. eResearchTechnology to Present at the Deutsche Bank 33rd Annual Healthcare Conference on May 7th 2008
8. eResearchTechnology Reports First Quarter 2008 Results
9. eResearchTechnology Announces Resignation of its CFO
10. eResearchTechnology to Present at the FBR 12th Annual Spring Investor Conference on May 28th 2008
11. eResearchTechnology Names New Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 Vestiage, Inc. ... company focused on science-based research and development, sales ... cosmeceuticals and nutraceuticals, announced today that it is ... for the sale of Reluma Skin Illuminating Facial ... and application by sending an email to info(at)vestiageinc(dot)com ...
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... 23, 2013 Patheon Inc ., ... to the global pharmaceutical industry, will host a complimentary ... to Testing” on Tuesday, June 4, 2013 at 11 ... are required to comply with regulations for cleaning validation. ... limited scientific underpinning and little evaluation of risk. ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 PI’s ... wide and provide 15 mm travel range with ... The small dimensions make these new positioners the ... spaces. A vacuum rated version is also available. ... specifications and datasheets can be found at: , ...
Breaking Biology Technology:Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2
... 2011 Orexigen ® Therapeutics, Inc. (Nasdaq: ... on the treatment of obesity, today announced that ... Morgan Healthcare Conference. The details are as follows: ... Pacific TimeLocation:  Westin St. Francis Hotel, San Francisco, ...
... Group, Inc. (OTC Bulletin Board: BONU ), ... has received correspondence from KHA Solutions Group following a ... Group, a for-profit entity and a wholly owned subsidiary ... into BioNeutral and its products, BioNeutral may be selected ...
... 2011 Cellular Dynamics International, Inc. (CDI), the world,s ... lines and tissue cells for drug discovery and safety, ... at the 29th Annual JPMorgan Healthcare Conference at 7:30 ... Francis Hotel in San Francisco. Robert Palay, chief executive ...
Cached Biology Technology:Kentucky Hospital Association Solutions Group Outlines Next Steps for BioNeutral Partnership 2Kentucky Hospital Association Solutions Group Outlines Next Steps for BioNeutral Partnership 3
(Date:5/23/2013)... Rollins School of Public Health at Emory University, ... Technology, have received a $4 million grant over ... Emory University (Health and Exposome Research Center: Understanding ... center grant awarded in the United States. ... National Institute of Environmental Health Sciences (NIEHS) of ...
(Date:5/23/2013)... wrapping of genomic DNA around nucleosomes in the ... A team of Ludwig-Maximilians-Universitaet (LMU) in Munich now ... be locally displaced from nucleosomes for transcription. , ... in the cell nucleus, wrapped around disk-shaped particles ... four different histone proteins and accommodating two loops ...
(Date:5/23/2013)... undergo surgery or harsh treatments because science fails ... forms of the disease. Researchers at Case Western ... developing technology that allows patients to safely choose ... or take drastic measures. , The project is ... of biomedical engineering at Case Western Reserve and ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Biochemistry: Unspooling DNA from nucleosomal disks 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3
... December 2, 2010 -- Intense, individually tailored dietary treatment ... mortality, according to a new study by researchers at ... just published in the prestigious Journal of the ... months after discharge (11.6 percent) of the control group ...
... year, dengue fever infects as many as 100 million people ... Both diseases are spread by infected female Aedes ... The blood feeding and the egg development are tightly linked ... a team of entomologists at the University of California, Riverside ...
... cited Pfeiffer,s research in biomedical imaging, and in particular ... approach has laid the foundation for applications of this ... to deliver improved image contrast with lower doses of ... from fundamental biophysical investigations to applications in medical imaging ...
Cached Biology News:Personalized diets for elderly after hospitalization decreases mortality rates 2Discovery by UC Riverside entomologists could shrink dengue-spreading mosquito population 2Physicist Franz Pfeiffer receives 2011 Leibniz Prize 2
... quick turnaround sequencing of individual research samples, ... copy plasmids. Agencourt's world-class, high performance sequencing ... per day. The key benefits of ... 24 48 hour sample turnaround, industry ...
A component of the Acridinium protein labeling kit....
... Sciences can provide custom microplate coating using advanced automated high ... of plate formats. We can also accommodate virtually any lot ... 0.5-320 L):, , 8 ... well microplate, 384 well microplate, ...
... HRP Conjugation Kits are based on ... that are consistent and reproducible. This ... conjugate your protein or antibody, including ... buffer. Activated HRP is supplied ...
Biology Products: